Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Other Non Operating Income for 4 consecutive years, with $158000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income rose 116.56% year-over-year to $158000.0, compared with a TTM value of $704000.0 through Sep 2025, up 190.03%, and an annual FY2024 reading of -$954000.0, down 59.0% over the prior year.
  • Other Non Operating Income was $158000.0 for Q3 2025 at Bicycle Therapeutics, down from $745000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $745000.0 in Q2 2025 and bottomed at -$954000.0 in Q3 2024.